ONCOMED PHARMACEUTICALS INC - COM (OMED)

CUSIP: 68234X102

Q4 2013 13F Holders as of 31 Dec 2013

Type / Class
Equity / COM
Total 13F shares
5,209,943
Share change
+9,751
Total reported value
$153,816,334
Price per share
$29.52
Number of holders
56
Value change
+$284,940
Number of buys
2
Number of sells
1

Quarterly Holders Quick Answers

What is CUSIP 68234X102?
CUSIP 68234X102 identifies OMED - ONCOMED PHARMACEUTICALS INC - COM in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of ONCOMED PHARMACEUTICALS INC - COM (OMED) as of Q4 2013

As of 31 Dec 2013, ONCOMED PHARMACEUTICALS INC - COM (OMED) was held by 56 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 5,209,943 shares. The largest 10 holders included Sectoral Asset Management Inc, BVF INC/IL, BlackRock Fund Advisors, COLUMBUS CIRCLE INVESTORS, PRIMECAP MANAGEMENT CO/CA/, Alyeska Investment Group, L.P., FRANKLIN RESOURCES INC, FMR LLC, DEUTSCHE BANK AG\, and VANGUARD GROUP INC. This page lists 56 institutional shareholders reporting positions in this security for the Q4 2013 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.